Erik H Knelson

8PUBLICATIONS
87CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 23, 2024
Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.

Takahiko Murayama, Navin R Mahadevan, Catherine B Meador

|Sep 06, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.

Ryohei Yoshida, Maria Saigi, Tetsuo Tani

|Jul 27, 2022
Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer Immunotherapies.

Marco Campisi, Sarah E Shelton, Minyue Chen

|Jul 05, 2022
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.

Gilles Berger, Erik H Knelson, Jorge L Jimenez-Macias

|Jun 09, 2022
Activation of Tumor-Cell STING Primes NK-Cell Therapy.

Erik H Knelson, Elena V Ivanova, Mubin Tarannum

|Nov 23, 2021
Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer.

Deli Hong, Erik H Knelson, Yixiang Li

Pageof 2

Frequent Collaborators

4 joint publications

Patrick H Lizotte

4 joint publications

David A Barbie

4 joint publications

Israel Cañadas

3 joint publications

Tetsuo Tani